JP2016519669A5 - - Google Patents

Download PDF

Info

Publication number
JP2016519669A5
JP2016519669A5 JP2016502940A JP2016502940A JP2016519669A5 JP 2016519669 A5 JP2016519669 A5 JP 2016519669A5 JP 2016502940 A JP2016502940 A JP 2016502940A JP 2016502940 A JP2016502940 A JP 2016502940A JP 2016519669 A5 JP2016519669 A5 JP 2016519669A5
Authority
JP
Japan
Prior art keywords
alkyl
compound
formula
alkylene
phenyl
Prior art date
Legal status (The legal status is an assumption and is not a legal conclusion. Google has not performed a legal analysis and makes no representation as to the accuracy of the status listed.)
Granted
Application number
JP2016502940A
Other languages
English (en)
Japanese (ja)
Other versions
JP2016519669A (ja
JP6368351B2 (ja
Filing date
Publication date
Application filed filed Critical
Priority claimed from PCT/US2014/028933 external-priority patent/WO2014144500A2/en
Publication of JP2016519669A publication Critical patent/JP2016519669A/ja
Publication of JP2016519669A5 publication Critical patent/JP2016519669A5/ja
Application granted granted Critical
Publication of JP6368351B2 publication Critical patent/JP6368351B2/ja
Expired - Fee Related legal-status Critical Current
Anticipated expiration legal-status Critical

Links

JP2016502940A 2013-03-15 2014-03-14 ジフルオロラクタムアナログを合成する方法 Expired - Fee Related JP6368351B2 (ja)

Applications Claiming Priority (3)

Application Number Priority Date Filing Date Title
US201361799334P 2013-03-15 2013-03-15
US61/799,334 2013-03-15
PCT/US2014/028933 WO2014144500A2 (en) 2013-03-15 2014-03-14 Methods of synthesizing a difluorolactam analog

Publications (3)

Publication Number Publication Date
JP2016519669A JP2016519669A (ja) 2016-07-07
JP2016519669A5 true JP2016519669A5 (https=) 2017-04-20
JP6368351B2 JP6368351B2 (ja) 2018-08-01

Family

ID=50693998

Family Applications (1)

Application Number Title Priority Date Filing Date
JP2016502940A Expired - Fee Related JP6368351B2 (ja) 2013-03-15 2014-03-14 ジフルオロラクタムアナログを合成する方法

Country Status (7)

Country Link
US (3) US9914725B2 (https=)
EP (1) EP2970234B1 (https=)
JP (1) JP6368351B2 (https=)
AU (1) AU2014229065B2 (https=)
CA (1) CA2903314C (https=)
IL (1) IL241042B (https=)
WO (1) WO2014144500A2 (https=)

Families Citing this family (3)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
WO2014015247A1 (en) * 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions
HU231033B1 (hu) * 2016-03-22 2019-12-30 CHINOIN Gyógyszer és Vegyészeti Termékek Gyára Zrt. Eljárás 3-as kötést tartalmazó optikailag aktív karbonsavak, karbonsav sók és karbonsav származékok előállítására
CN106699604B (zh) * 2017-01-09 2019-01-01 四川同晟生物医药有限公司 一种沙库比曲及其中间体的制备方法

Family Cites Families (26)

* Cited by examiner, † Cited by third party
Publication number Priority date Publication date Assignee Title
US3975399A (en) 1974-08-06 1976-08-17 E. I. Du Pont De Nemours And Company 1,5-Disubstituted-2-pyrrolidinones, -3-pyrrolin-2-ones, and -4-pyrrolin-2-ones
DE2517771A1 (de) 1975-04-18 1976-10-28 Schering Ag Neue prostaglandin-acetylen-analoga und verfahren zu ihrer herstellung
CA1085859A (en) 1975-06-27 1980-09-16 Wilhelm Bartmann Pyrrolidones and process for their manufacture
DE2528664A1 (de) 1975-06-27 1977-01-13 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
DE2619638A1 (de) 1976-05-04 1977-11-17 Hoechst Ag Pyrrolidone und verfahren zu ihrer herstellung
US4177346A (en) 1976-08-06 1979-12-04 Pfizer Inc. 1,5-Disubstituted-2-pyrrolidones
US4320136A (en) 1980-08-11 1982-03-16 E. I. Du Pont De Nemours And Company 8-Aza-16,16-difluoroprostanoids
US4311644A (en) * 1981-01-30 1982-01-19 E. R. Squibb & Sons, Inc. Method for preparing 10,10-difluoro prostacyclin intermediates and new compounds produced thereby
US4456613A (en) 1982-12-27 1984-06-26 E. I. Du Pont De Nemours And Company 6-Keto- and 6-hydroxy-8-azaprostanoids and anti-ulcer use thereof
OA12533A (en) 2000-11-27 2006-06-05 Pfizer Prod Inc Ep4 receptor selective agonists in the treatment of osteoporosis.
AU2002226035A1 (en) * 2000-12-07 2002-06-18 Michael P Doyle Lewis acid catalysis using chiral metal complexes
CA2451392A1 (en) 2001-07-16 2003-01-30 F. Hoffmann-La Roche Ag Prostaglandin analogues as ep4 receptor agonists
CN100371322C (zh) 2001-07-16 2008-02-27 霍夫曼-拉罗奇有限公司 作为前列腺素类化合物激动剂的2-吡咯烷酮衍生物
EP2255829A3 (en) * 2001-07-23 2012-03-28 Ono Pharmaceutical Co., Ltd. Pharmaceutical composition for treatment of diseases associated with decrease in bone mass comprising EP4 agonist as active ingredient
EP1461026A2 (en) 2001-12-03 2004-09-29 Merck & Co., Inc. Method for treating ocular hypertension
WO2003077910A1 (en) 2002-03-18 2003-09-25 Pfizer Products Inc. Methods of treatment with selective ep4 receptor agonists
AU2003233729B2 (en) 2002-06-06 2007-10-04 Merck Frosst Canada Ltd 1,5-distributed pyrrolid-2-one derivatives for use as EP4 receptor agonists in the treatment of eye diseases such as glaucoma
JP4754820B2 (ja) 2002-06-10 2011-08-24 メルク セローノ ソシエテ アノニム プロスタグランジン作動薬としてのγラクタムおよびその使用
US20060167081A1 (en) 2002-10-25 2006-07-27 Xavier Billot Ep4 receptor agonists
ES2305779T3 (es) 2003-03-03 2008-11-01 Laboratoires Serono Sa Derivados de g-lactama como agonistas de prostaglandinas.
KR20100044251A (ko) 2007-08-15 2010-04-29 싸이토키네틱스, 인코포레이티드 특정 화학 물질, 조성물 및 방법
WO2009055289A2 (en) 2007-10-23 2009-04-30 Allergan, Inc. Therapeutic substituted lactams
US20120270934A1 (en) 2009-07-03 2012-10-25 Concert Pharmaceuticals, Inc. Prostacyclin derivatives
CN103201261A (zh) 2010-11-10 2013-07-10 埃科特莱茵药品有限公司 用作为食欲素受体拮抗剂的内酰胺衍生物
EP2729445B1 (en) * 2011-07-04 2015-10-21 Rottapharm Biotech S.r.l. Cyclic amine derivatives as ep4 receptor antagonists
WO2014015247A1 (en) * 2012-07-19 2014-01-23 Cayman Chemical Company, Inc. Difluorolactam compounds as ep4 receptor-selective agonists for use in the treatment of ep4-mediated disease and conditions

Similar Documents

Publication Publication Date Title
JP2016512823A5 (https=)
JP2010513494A5 (https=)
WO2016041508A1 (zh) 一种噁唑烷酮类化合物及其中间体的制备方法
JP2015524822A (ja) インテグラーゼインヒビターを調製するためのプロセスおよび中間体
JP2019048838A (ja) α,ω−ジカルボン酸末端ジアルカンエーテルを調製するためのプロセスおよび中間体
JP2016519669A5 (https=)
JP2014527508A5 (https=)
CN1918168B (zh) 制备3-o-保护吗啡酮和3-o-保护吗啡酮二烯醇羧酸酯的方法
WO2015012110A1 (ja) C-グリコシド誘導体の製造方法
JP6388065B2 (ja) ジフルオロエステル化合物の製造方法
JP6368351B2 (ja) ジフルオロラクタムアナログを合成する方法
JP7109029B2 (ja) Pge1コアブロック誘導体およびその製造方法
JP2013514344A (ja) 4−ブロモメチル−[1,1’−ビフェニル]−2’−カルボニトリルの調製方法
EP3521293B1 (en) Process for the preparation of an inhibitor of phosphodiesterase 4
CN105377818B (zh) 用于制备埃替拉韦的新方法
KR101821685B1 (ko) 베라프로스트 제조 중간체의 제조방법
WO2000035898A1 (en) HYDRONAPHTHO[2,3-c]FURAN DERIVATIVES AND PROCESS FOR THE PREPARATION THEREOF
US9708284B2 (en) Process for the preparation of olopatadine and sylil intermediates thereof
WO2014108011A1 (zh) 恩替卡韦中间体及其制备方法
JP4902247B2 (ja) 2−(1−ベンゾチオフェン−5−イル)エタノールの新規製造法およびその中間体
JP5763313B2 (ja) 2−(1−ベンゾチオフェン−5−イル)エタノールの製造法
JP2012521993A (ja) 縮合三環式スルホンアミドの製造プロセス
JPWO2011065351A1 (ja) シクロヘキサン誘導体の製造方法
TW201827421A (zh) 用於製備殺蟲化合物之方法
JPWO2007021001A1 (ja) 2,3,4−トリフルオロ−5−置換安息香酸化合物及びその製法